Division of Medical Oncology C, Istituto Nazionale per la Ricerca sul Cancro, IST, Genova, Italy.
Mol Med. 2011;17(7-8):834-9. doi: 10.2119/molmed.2011.00047. Epub 2011 Apr 28.
The mutational status of the immunoglobulin heavy-chain variable region (IGHV) genes utilized by chronic lymphocytic leukemia (CLL) clones defines two disease subgroups. Patients with unmutated IGHV have a more aggressive disease and a worse outcome than patients with cells having somatic IGHV gene mutations. Moreover, up to 30% of the unmutated CLL clones exhibit very similar or identical B cell receptors (BcR), often encoded by the same IG genes. These "stereotyped" BcRs have been classified into defined subsets. The presence of an IGHV gene somatic mutation and the utilization of a skewed gene repertoire compared with normal B cells together with the expression of stereotyped receptors by unmutated CLL clones may indicate stimulation/selection by antigenic epitopes. This antigenic stimulation may occur prior to or during neoplastic transformation, but it is unknown whether this stimulation/selection continues after leukemogenesis has ceased. In this study, we focused on seven CLL cases with stereotyped BcR Subset #8 found among a cohort of 700 patients; in six, the cells expressed IgG and utilized IGHV4-39 and IGKV1-39/IGKV1D-39 genes, as reported for Subset #8 BcR. One case exhibited special features, including expression of IgM or IgG by different subclones consequent to an isotype switch, allelic inclusion at the IGH locus in the IgM-expressing cells and a particular pattern of cytogenetic lesions. Collectively, the data indicate a process of antigenic stimulation/selection of the fully transformed CLL cells leading to the expansion of the Subset #8 IgG-bearing subclone.
慢性淋巴细胞白血病 (CLL) 克隆利用的免疫球蛋白重链可变区 (IGHV) 基因的突变状态定义了两个疾病亚组。未突变 IGHV 的患者比具有体细胞 IGHV 基因突变的患者具有更具侵袭性的疾病和更差的预后。此外,多达 30%的未突变 CLL 克隆表现出非常相似或相同的 B 细胞受体 (BcR),通常由相同的 IG 基因编码。这些“定型”的 BcR 已被分类为定义明确的亚组。IGHV 基因体细胞突变的存在和与正常 B 细胞相比利用偏向的基因库以及未突变 CLL 克隆表达定型受体可能表明受抗原表位的刺激/选择。这种抗原刺激可能发生在肿瘤转化之前或期间,但尚不清楚这种刺激/选择是否在白血病发生后继续存在。在这项研究中,我们专注于在 700 例患者队列中发现的七个具有定型 BcR 亚组 #8 的 CLL 病例;在其中 6 个病例中,细胞表达 IgG 并利用 IGHV4-39 和 IGKV1-39/IGKV1D-39 基因,如亚组 #8 BcR 所报道。一个病例表现出特殊特征,包括不同亚克隆由于同种型转换而表达 IgM 或 IgG、在表达 IgM 的细胞中 IGH 基因座的等位基因包含以及特定的细胞遗传学损伤模式。总的来说,这些数据表明完全转化的 CLL 细胞经历了抗原刺激/选择的过程,导致亚组 #8 携带 IgG 的亚克隆的扩增。